<DOC>
	<DOC>NCT00233389</DOC>
	<brief_summary>To examine the efficacy of continued administration of rebamipide following bacteria eradication therapy in patients with H. pylori-positive active gastric ulcer in a placebo-controlled, double-blind study</brief_summary>
	<brief_title>Post-Marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>1. Patients aged 20 years or older at time of consent 2. H. pyloripositive patients meeting both of the following criteria:• Assessed as H. pyloripositive by rapid urease test and/or 13Curea breath test at prestudy examination, • Assessed as H. pyloriantibodypositive by urinebased test after obtaining informed consent 3. Patients endoscopically diagnosed with gastric ulcer meeting the following criteria:• Active (A1 or A2stage by Sakita/Miwa classification）, • Solitary, • Longitudinal diameter: &gt;5 mm 4. Patients who have not received proton pump inhibitors (PPIs), antibacterial agents, or antiprotozoal agents within 1 week prior to endoscopy 1. Patients who have previously received H. pylori eradication therapy 2. Patients with acute gastric ulcer 3. Patients with linear ulcer 4. Patients with complication of duodenal ulcer (excluding cicatrix) 5. Patients who have undergone upperGI tract or vagal nerve resection 6. Patients who are unsuitable for pharmacotherapy, e.g., with perforation or pyloric stenosis 7. Patients with gastric ulcer considered likely to induce massive hemorrhage (e.g., with obviously exposed blood vessels at lesion sites) 8. Patients with a history of amoxicillin shock 9. Patients with infectious mononucleosis 10. Patients with severe renal disorders 11. Patients with a history of hypersensitivity to penicillins, clarithromycin, lansoprazole, or rebamipide 12. Patients who have been treated with drugs contraindicated to clarithromycin, such as terfenadine, cisapride, and pimozide 13. Patients who are pregnant, possibly pregnant, lactating, or who desire to become pregnant during the study 14. Patients who are otherwise judged inappropriate for inclusion in the study by the investigator or subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>